1. ALLA AKTIER
  2. NYHETER
  3. NEOLA MEDICAL

Neola Medical

Nyheter Neola Medical Nyheter alla bolag

Neola Medical invites to presentation of the Q2-report 2024

Neola Medical AB (publ) invites to presentation of the Q2-report of 2024, Thursday the 15th of August 2024 at 12:30 CET (12.30). The presentation will be held online as a webcast hosted by Finwire. The Q2-report will be published the same morning.

Neola Medical publishes the Q2-report in the morning the 15th of August 2024. We hereby invite investors, analysts, and journalists to a combined report presentation and webcast Thursday the 15th of August 2024 at 12:30 CET (12.30). The report will be presented by CEO Hanna Sjöström and CFO Christian Gyllenberg.

Watch the presentation here: https://www.finwire.tv/webcast/neola-medical/q2-2024/ where you also can type in questions in advance and during the presentation that we will be answering live during the Q&A after the presentation.

For further questions after the presentation, contact CFO Christian Gyllenberg through below contact details.

The report and report presentation will be available at Neola Medical’s website:
https://www.neolamedical.com/investors/rapporter-och-finansiell-kalender/

For further information, contact:
Hanna Sjöström, CEO
e-mail: hanna.sjostrom@neolamedical.com
Christian Gyllenberg, CFO
e-mail: christian.gyllenberg@neolamedical.com

About Neola Medical
Neola Medical AB (publ) develops revolutionizing medical technology device for non-invasive continuous lung monitoring and real-time alerts of life-threatening lung complications of preterm born infants. Immediate detection of complications provides the possibility of early treatment, improved health care and healthier lives for preterm born infants. The patented cutting-edge technology is developed at Lund University in Sweden and based on a spectroscopic method that measures lung volume changes and oxygen gas concentration. Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care. The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.

Attachments
Neola Medical invites to presentation of the Q2-report 2024

Datum 2024-08-06, kl 13:50
Källa MFN
Bifogade filer
Neola Medical invites to presentation of the Q2-report 2024
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!